Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial
- 1 June 1999
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 353 (9169) , 1993-2000
- https://doi.org/10.1016/s0140-6736(99)05036-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.Journal of Clinical Oncology, 1998
- Lumpectomy Compared with Lumpectomy and Radiation Therapy for the Treatment of Intraductal Breast CancerNew England Journal of Medicine, 1993
- New Perspective on Cancer of the Contralateral Breast: A Marker for Assessing Tamoxifen as a Preventive AgentJNCI Journal of the National Cancer Institute, 1991
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- Five-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Segmental Mastectomy with or without Radiation in the Treatment of Breast CancerNew England Journal of Medicine, 1985
- Duct carcinoma in situ . Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short‐term treatment failuresCancer, 1982
- Noninvasive Breast CarcinomaAnnals of Surgery, 1980
- Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma modelPublished by Elsevier ,1980
- Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomataPublished by Elsevier ,1976